tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Acne Vulgaris D000152 35 associated lipids
Urination Disorders D014555 9 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteochondrodysplasias D010009 3 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Nakagawa K et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. 2015 Am. J. Reprod. Immunol. pmid:25394810
Cury Martins J et al. Topical tacrolimus for atopic dermatitis. 2015 Cochrane Database Syst Rev pmid:26132597
Prinz V et al. MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection. 2015 J. Cereb. Blood Flow Metab. pmid:26126863
Cantaluppi V et al. Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. 2015 PLoS ONE pmid:26125566
Fukahori H et al. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation. 2015 Int. Immunopharmacol. pmid:26122135
Eidens M et al. Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping. 2015 Clin. Lab. pmid:25975003
Safa K et al. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. 2015 Clin. Nephrol. pmid:24495904
Gordon P and Gooptu B Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders. 2015 Rheumatology (Oxford) pmid:25342374
Shi WL et al. Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis. 2015 PLoS ONE pmid:26039043
Wozniak LJ et al. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. 2015 Transplantation pmid:26038872
Staatz CE and Tett SE Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients. 2015 Clin Pharmacokinet pmid:26038096
Migita K et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. 2015 Arthritis Res. Ther. pmid:26036592
van Boekel GA et al. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique. 2015 Eur. J. Clin. Pharmacol. pmid:25980838
de Jonge H et al. The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients. 2015 Pharmacogenomics J. pmid:25287072
Jin S et al. Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin. 2015 Gastroenterology pmid:25980752
Wiseman AC Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know. 2015 Clin J Am Soc Nephrol pmid:25979977
Ratanatharathorn V et al. Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT. 2015 Bone Marrow Transplant. pmid:25285804
Tanriover B et al. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. 2015 Clin J Am Soc Nephrol pmid:25979971
Kang YZ et al. Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation. 2015 World J. Gastroenterol. pmid:25717264
Blasco-Morente G et al. Long-Standing Presternal Plaque. 2015 Actas Dermosifiliogr pmid:25917959
Ferraresso M et al. Relationship between mRNA expression levels of CYP3A4, CYP3A5 and SXR in peripheral mononuclear blood cells and aging in young kidney transplant recipients under tacrolimus treatment. 2015 Pharmacogenomics pmid:25916520
Nagaya M et al. A new system to evaluate the influence of immunosuppressive drugs on pancreatic islets using epigenetic analysis in a 3-dimensional culture. 2015 Pancreas pmid:25906448
Wang M et al. Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. 2015 Biomacromolecules pmid:25714622
Josephson MA et al. American society of Nephrology Quiz and Questionnaire 2014: transplantation. 2015 Clin J Am Soc Nephrol pmid:25862775
Peña C et al. [Secondary acute myeloid leukemia in a lung allograft recipient. Report of one case]. 2015 Rev Med Chil pmid:25860370
Selk A A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus. 2015 J Low Genit Tract Dis pmid:25853633
Hurst AL et al. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients. 2015 Pediatr Transplant pmid:25850753
Wang L et al. Effect of CYP3A5 gene polymorphisms on tacrolimus concentration/dosage ratio in adult liver transplant patients. 2015 Genet. Mol. Res. pmid:26634478
Romanowski M et al. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Pharmacogenomics pmid:26282401
Solomon SR et al. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. 2015 Biol. Blood Marrow Transplant. pmid:25797174
Dedinská I et al. Waist circumference as an independent risk factor for NODAT. 2015 Ann. Transplant. pmid:25791039
Suzuki N et al. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. 2015 PLoS ONE pmid:25790231
Abe Y et al. Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus. 2015 Intern. Med. pmid:26568012
Heneberg P et al. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro. 2015 PLoS ONE pmid:26562153
Yang CJ et al. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes. 2015 Biochemistry pmid:26561008
Dias PH et al. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion. 2015 Acta Cir Bras pmid:25714692
San Miguel C et al. Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital. 2015 Transplant. Proc. pmid:26518930
Jóźwiak-Bębenista M et al. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation. 2015 Pharmacol Rep pmid:25712659
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Katayama K et al. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice. 2015 Mod Rheumatol pmid:24983407
Yessayan L et al. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation. 2015 Transplant. Proc. pmid:26707323
Wang Y et al. Justification of noninferiority margin: methodology considerations in an exposure-response analysis. 2015 Clin. Pharmacol. Ther. pmid:25670256
Dumortier T et al. Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approach. 2015 Clin. Pharmacol. Ther. pmid:25669933
Yoon NY et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. 2015 Arch. Dermatol. Res. pmid:25786383
Tanaka M et al. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. 2015 Mult. Scler. pmid:25662352
Dai DS et al. Protective Effect of Salvia Przewalskii Extract on Puromycin-Induced Podocyte Injury. 2015 Am. J. Nephrol. pmid:26439819
Wu SC et al. Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing. 2015 Dis. Markers pmid:26435568
Okechuku G et al. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. 2015 Pediatr Transplant pmid:25661468
Xie X et al. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. 2015 BMC Nephrol pmid:26126806
Kume K et al. Screening for a gene deletion mutant whose temperature sensitivity is suppressed by FK506 in budding yeast and its application for a positive screening for drugs inhibiting calcineurin. 2015 Biosci. Biotechnol. Biochem. pmid:25614218
Garnock-Jones KP Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. 2015 Drugs pmid:25613762
Oguni H and Hayashi M [Topics for authorization of new intravenous antiepileptic drugs and tacrolimus for autoimmune epilepsy]. 2015 No To Hattatsu pmid:26349372
Dave CN et al. Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. 2015 Int Urol Nephrol pmid:26347076
Wu J et al. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. 2015 J. Clin. Invest. pmid:26436650
Overk CR et al. Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506. 2015 Neuroscience pmid:26341908
Bhadauria D et al. Cryptosporidium infection after renal transplantation in an endemic area. 2015 Transpl Infect Dis pmid:25620388
Luger T et al. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. 2015 Pediatr Allergy Immunol pmid:25557211
Schnitzbauer AA et al. Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. 2015 Ann. Transplant. pmid:25553853
Burke MT et al. Genetics and nonmelanoma skin cancer in kidney transplant recipients. 2015 Pharmacogenomics pmid:25616102
Schnitzler F et al. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. 2015 PLoS ONE pmid:26288187
Aruch DB and Renteria A Simultaneous PRES and TMA secondary to tacrolimus after allogeneic bone marrow transplant. 2015 Blood pmid:26287041
Chakraborty S et al. Prediction of in vivo drug performance using in vitro dissolution coupled with STELLA: a study with selected drug products. 2015 Drug Dev Ind Pharm pmid:25494535
Hauch A et al. Generics: are all immunosuppression agents created equally? 2015 Surgery pmid:26206317
Gong N et al. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients. 2015 Cell. Immunol. pmid:26205091
Chamani G et al. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. 2015 Int. J. Dermatol. pmid:26204904
Türkoğlu O et al. Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? 2015 Arch. Oral Biol. pmid:25555253
Rivinius R et al. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. 2015 Drug Des Devel Ther pmid:25552900
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Filler G and Smith N The need for tacrolimus assay standardization. 2014 Ther Drug Monit pmid:25390282
Sachewsky N et al. Cyclosporin A enhances neural precursor cell survival in mice through a calcineurin-independent pathway. 2014 Dis Model Mech pmid:25056698
Erdinest N and Solomon A Topical immunomodulators in the management of allergic eye diseases. 2014 Curr Opin Allergy Clin Immunol pmid:25054831
Yin Z et al. Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin. 2014 Drug Des Devel Ther pmid:25336924
Rehman S et al. Effect of different tacrolimus levels on early outcomes after kidney transplantation. 2014 Ann. Transplant. pmid:24509826
Balato A et al. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. 2014 Mycoses pmid:24512536
Qin XL et al. In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus. 2014 Drug Metab. Dispos. pmid:24195812
Silva-Cunha A et al. Evaluation of the pharmacokinetics and ocular tolerance of a microemulsion containing tacrolimus. 2014 J Ocul Pharmacol Ther pmid:24199740
Bruel A et al. Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression. 2014 Pediatr Transplant pmid:24341571
Sapir-Pichhadze R et al. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. 2014 Kidney Int. pmid:24336032
Teraki Y [Atopic dermatitis in pregnancy]. 2014 Arerugi pmid:24714179
Jalil MH et al. Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients. 2014 Br J Clin Pharmacol pmid:23738951
Deng Z et al. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation]. 2014 Zhonghua Er Ke Za Zhi pmid:25224233
Peloso LJ et al. The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. 2014 Transplantation pmid:25221905
Tanaka H et al. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. 2014 Lupus pmid:24651669
Pichler R et al. De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. 2014 Urol. Int. pmid:25115614
Yan YH et al. Role of FK506 binding protein 12 in morphine-induced μ-opioid receptor internalization and desensitization. 2014 Neurosci. Lett. pmid:24607931
Bogan JS Endocytic cycling of glucose transporters and insulin resistance due to immunosuppressive agents. 2014 J. Clin. Endocrinol. Metab. pmid:25279573
Demmers MW et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. 2014 Transplantation pmid:24157471
Kraus TS et al. Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient. 2014 Acta Haematol. pmid:24157860
Hostettler KE et al. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. 2014 Eur. Respir. J. pmid:23645405
Kuramitsu S et al. [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy]. 2014 Fukuoka Igaku Zasshi pmid:25000660
Wohlfahrtova M and Viklicky O Recent trials in immunosuppression and their consequences for current therapy. 2014 Curr Opin Organ Transplant pmid:24905020
Boonyapredee M et al. Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection. 2014 Mil Med pmid:24902140
Reitamo S and Remitz A An update on current pharmacotherapy options in atopic dermatitis. 2014 Expert Opin Pharmacother pmid:24811606
Stifft F et al. Rectal and sublingual administration of tacrolimus: a single-dose pharmacokinetic study in healthy volunteers. 2014 Br J Clin Pharmacol pmid:24809233
Yamanaka M et al. Development and evaluation of a tacrolimus cream formulation using a binary solvent system. 2014 Int J Pharm pmid:24456671
Levy G et al. REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C. 2014 Am. J. Transplant. pmid:24456049
Miller EC et al. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits. 2014 Eur. J. Neurosci. pmid:24713000